166 related articles for article (PubMed ID: 19282302)
1. Steroid profiles of professional soccer players: an international comparative study.
Strahm E; Sottas PE; Schweizer C; Saugy M; Dvorak J; Saudan C
Br J Sports Med; 2009 Dec; 43(14):1126-30. PubMed ID: 19282302
[TBL] [Abstract][Full Text] [Related]
2. Dose-dependent testosterone sensitivity of the steroidal passport and GC-C-IRMS analysis in relation to the UGT2B17 deletion polymorphism.
Strahm E; Mullen JE; Gårevik N; Ericsson M; Schulze JJ; Rane A; Ekström L
Drug Test Anal; 2015; 7(11-12):1063-70. PubMed ID: 26198073
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological investigation of the UGT2B17 polymorphism in doping control urine samples and its correlation to T/E ratios.
Anielski P; Simmchen J; Wassill L; Ganghofner D; Thieme D
Drug Test Anal; 2011 Oct; 3(10):645-51. PubMed ID: 21928278
[TBL] [Abstract][Full Text] [Related]
4. Subject-based steroid profiling and the determination of novel biomarkers for DHT and DHEA misuse in sports.
Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
Drug Test Anal; 2010; 2(11-12):582-8. PubMed ID: 21204290
[TBL] [Abstract][Full Text] [Related]
5. Discordant genotyping results using DNA isolated from anti-doping control urine samples.
Choong E; Schulze JJ; Ericsson M; Rane A; Ekström L
Drug Test Anal; 2017 Jul; 9(7):994-1000. PubMed ID: 27706926
[TBL] [Abstract][Full Text] [Related]
6. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports.
Van Renterghem P; Van Eenoo P; Sottas PE; Saugy M; Delbeke F
Clin Endocrinol (Oxf); 2011 Jul; 75(1):134-40. PubMed ID: 21521264
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of blood steroidal passport markers for detecting testosterone abuse in Asians.
Okano M; Shiomura S
Drug Test Anal; 2024 Jun; 16(6):595-603. PubMed ID: 37848395
[TBL] [Abstract][Full Text] [Related]
8. Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.
Schulze JJ; Lundmark J; Garle M; Ekström L; Sottas PE; Rane A
Steroids; 2009 Mar; 74(3):365-8. PubMed ID: 19056415
[TBL] [Abstract][Full Text] [Related]
9. UDP-glucuronosyltransferase 2B17 genotyping in Japanese athletes and evaluation of the current sports drug testing for detecting testosterone misuse.
Okano M; Ueda T; Nishitani Y; Kano H; Ikekita A; Kageyama S
Drug Test Anal; 2013 Mar; 5(3):166-81. PubMed ID: 22887913
[TBL] [Abstract][Full Text] [Related]
10. Detection of testosterone administration based on the carbon isotope ratio profiling of endogenous steroids: international reference populations of professional soccer players.
Strahm E; Emery C; Saugy M; Dvorak J; Saudan C
Br J Sports Med; 2009 Dec; 43(13):1041-4. PubMed ID: 19549614
[TBL] [Abstract][Full Text] [Related]
11. Influences of musk administration on the doping test.
He Y; Wang J; Liu X; Xu Y; He Z
Steroids; 2013 Nov; 78(11):1047-52. PubMed ID: 23891647
[TBL] [Abstract][Full Text] [Related]
12. Profiling of urinary steroids by gas chromatography-mass spectrometry detection and confirmation of androstenedione administration using isotope ratio mass spectrometry.
Wang J; Wu M; Liu X; Xu Y
Steroids; 2011 Dec; 76(14):1560-5. PubMed ID: 21945895
[TBL] [Abstract][Full Text] [Related]
13. Reference ranges for the urinary steroid profile in a Latin-American population.
Martínez-Brito D; Correa Vidal MT; de la Torre X; García-Mir V; Ledea Lozano O; Granda Fraga M
Drug Test Anal; 2013 Aug; 5(8):619-26. PubMed ID: 23339119
[TBL] [Abstract][Full Text] [Related]
14. Combination of carbon isotope ratio with hydrogen isotope ratio determinations in sports drug testing.
Piper T; Emery C; Thomas A; Saugy M; Thevis M
Anal Bioanal Chem; 2013 Jun; 405(16):5455-66. PubMed ID: 23568614
[TBL] [Abstract][Full Text] [Related]
15. From population- to subject-based limits of T/E ratio to detect testosterone abuse in elite sports.
Sottas PE; Saudan C; Schweizer C; Baume N; Mangin P; Saugy M
Forensic Sci Int; 2008 Jan; 174(2-3):166-72. PubMed ID: 17485185
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing the steroid profile in doping control analysis.
Mareck U; Geyer H; Opfermann G; Thevis M; Schänzer W
J Mass Spectrom; 2008 Jul; 43(7):877-91. PubMed ID: 18570179
[TBL] [Abstract][Full Text] [Related]
17. Testosterone challenge and androgen receptor activity in relation to UGT2B17 genotypes.
Ekström L; Cevenini L; Michelini E; Schulze J; Thörngren JO; Belanger A; Guillemette C; Garle M; Roda A; Rane A
Eur J Clin Invest; 2013 Mar; 43(3):248-55. PubMed ID: 23294483
[TBL] [Abstract][Full Text] [Related]
18. Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.
Schulze JJ; Lundmark J; Garle M; Skilving I; Ekström L; Rane A
J Clin Endocrinol Metab; 2008 Jul; 93(7):2500-6. PubMed ID: 18334593
[TBL] [Abstract][Full Text] [Related]
19. Drug testing data from the 2007 Pan American Games: delta13C values of urinary androsterone, etiocholanolone and androstanediols determined by GC/C/IRMS.
Aguilera R; Chapman TE; Pereira H; Oliveira GC; Illanes RP; Fernandes TF; Azevedo DA; Neto FA
J Steroid Biochem Mol Biol; 2009 Jul; 115(3-5):107-14. PubMed ID: 19428237
[TBL] [Abstract][Full Text] [Related]
20. Development of a GC/C/IRMS method--confirmation of a novel steroid profiling approach in doping control.
Van Renterghem P; Polet M; Brooker L; Van Gansbeke W; Van Eenoo P
Steroids; 2012 Sep; 77(11):1050-60. PubMed ID: 22728892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
